UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

Eastman Kodak Company

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

277461 40 6

(CUSIP Number)

Moses Marx

160 Broadway - 1^st Floor

New York, New York 10038

(212) 349 - 2875

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

July 28, 2020

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

¹ Includes 50,000 shares of Common Stock (as defined in Item 1) held directly; 1,519,646 shares of Common Stock held by United Equities Commodities Company; 614,041 shares of Common Stock held by Marneu Holding Company; and 170,000 shares of Common Stock held by 111 John Realty Corp.

² The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

¹ The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

¹The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

¹The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

¹ The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

¹ The percentage set forth in Row 13 of this Cover Page is based on the 75,494,534 shares of Common Stock of the Issuer (as defined in Item 1) outstanding as of July 31, 2020, as reported on Form 8-K (as defined in Item 5).

Item 1. Security and Issuer.

This Amendment No. 3 amends the initial statement on Schedule 13D filed on September 13, 2013, as amended on May 3, 2017 and December 3, 2019 (as amended, the “Statement”) relating to the common stock, $0.01 par value per share (“Common Stock”), of Eastman Kodak Company, a New Jersey corporation (the “Issuer”). The address of the Issuer’s principal executive offices is 343 State Street, Rochester, New York, NY 14650.

Item 2. Identity and Background.

(a)      This Statement is being filed by Moses Marx, an individual, Momar Corporation, a New York corporation (“Momar”), Marneu Holding company, a New York general partnership (“Marneu”), United Equities Commodities Company, a New York general partnership (“UECC”), 111 John Realty Corp., a New York corporation (“111 John”) and K.F. Investors LLC, a New York limited liability company (“KF Investors”). The individual and entities hereinabove set forth (collectively, the “Reporting Persons”) are making this single, joint filing because they have agreed to act as a “group” within the meaning of Section 13(d)(3) of the Exchange Act. Set forth below is information regarding Mr. Marx, Momar, Marneu, UECC, 111 John and KF Investors in response to Item 2 of Schedule 13D. The business address for the persons named in Item 2(a) is 160 Broadway, New York, NY 10038.

(b)–(c)

Mr. Marx is principally employed as a private investor.

Momar is a New York corporation. Pursuant to Instruction C to Schedule 13D, Dr. Joseph Fink is the interim President and Vice President and Treasurer of Momar, and Philippe D. Katz is Vice President and Secretary of Momar. Messrs. Fink and Katz are the directors of Momar. No person is a controlling shareholder of Momar. Each of Dr. Fink and Mr. Katz is principally employed as a private investor and their principal business address is 160 Broadway, New York, New York 10038. Mr. Marx has no ownership interest in nor any control of Momar.

Marneu is a New York general partnership. Pursuant to Instruction C to Schedule 13D, the general partners of Marneu are Moses Marx and United Equities Realty Associates, a New York general partnership, the general partners of which are Mr. Marx, Dr. Fink and Mr. Katz. Mr. Marx holds a direct and indirect 71.4285% general partnership interest in Marneu.

UECC is a New York general partnership. Pursuant to Instruction C to Schedule 13D, the general partners of UECC are Mr. Marx, Dr. Fink and Mr. Katz. Mr. Marx holds a 99% general partnership interest in UECC.

111 John is a New York corporation. Pursuant to Instruction C to Schedule 13D, Mr. Marx, Dr. Fink and Mr. Katz comprise the Board of Directors and are President, Treasurer and Secretary, respectively of 111 John.

KF Investors is a New York limited liability company. Pursuant to Instruction C to Schedule 13D, the Manager of KF Investors are Dr. Fink and Mr. Katz. Mr. Marx has no ownership interest in nor any control of KF Investors.

(d)       During the last five years, none of the persons named in Item 2(a) above was convicted in a criminal proceeding, excluding traffic violations or similar misdemeanors.

(e)        During the last five years, none of the persons named in Item 2(a) above was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of which was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f)        All individuals named herein are citizens of the United States.

Item 3. Source and Amount of Funds or Other Consideration.

All securities described in this Schedule 13D were acquired by the respective Reporting Persons using their own funds.

Item 4. Purpose of Transaction.

The Reporting Persons acquired the Common Stock for investment purposes. Depending upon market conditions and other factors that the Reporting Persons deem material, they may purchase additional Common Stock or other securities of the Issuer in the open market, private transactions or from the Issuer, or may dispose of all or a portion of the Common Stock or other securities of the Issuer that they now own or may hereafter acquire.

Mr. Katz, whose affiliation with certain of the Reporting Persons is described in Item 2, serves as a member of the Board of Directors of the Issuer. As such, he participates in the planning and decisions of the Board of Directors and management of the Issuer.

Except as discussed in this Statement, none of the persons named in Item 2(a) above has any present plans or proposals which relate to or would result in any of the following:

(a)                The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;

(b)               An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

(c)                A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;

(d)               Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

(e)                Any material change in the present capitalization or dividend policy of the Issuer;

(f)                Any other material change in the Issuer’s business or corporate structure;

(g)               Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;

(h)               Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

(i)                 A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

(j)                 Any action similar to any of those enumerated above.

Item 5. Interest in Securities of the Issuer.

(a)-(b) All percentages set forth in this Schedule 13D are based on the Issuer’s 75,494,534 shares of Common Stock outstanding as of July 31, 2020, as reported on the Issuer’s Form 8-K filed with the Securities and Exchange Commission on August 3, 2020 (“Form 8-K”). The Information set forth in rows 7-13 of each Cover Page of this Schedule 13D is hereby incorporated by reference. On July 28, 2020, Mr. Marx resigned as President and Director of Momar and thus has no beneficial interest in the shares of Common Stock owned by Momar. In addition to the shares set forth on each Cover Page, Mr. Katz, whose affiliation with certain of the Reporting Persons is described in Item 2, owns 116,368 shares of Common Stock directly as well as 30,214 options that are excercisable either currently or within the next 60 days.

Each of the Reporting Persons expressly declares that this filing shall not be construed as an admission that such Reporting Person is, for the purposes of sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this filing other than those reported as owned by such Reporting Person directly.

None of the persons named in Item 2(a) above beneficially own any other shares of Common Stock of the Issuer.

(c)       On July 29, 2020, Mr. Marx sold 53,729 shares of Common Stock at an average sale price of $18.17 per share and 196,574 shares of Common Stock at an average sale price of $40.41 per share, in open market transactions.

On June 11, 2020, Mr. Katz purchased 5,000 shares of Common Stock at an average price of $2.48 per share in open market transactions and on June 23, 2020, Mr. Katz purchased 5,000 shares of Common Stock at an average price of $2.22 per share in open market transactions.

Except for the shares of Common Stock acquired in the transactions described in this Statement, none of the persons named in Item 2(a) above has effected any transaction in shares of Common Stock during the 60 days preceding the date of this Statement.

(d)       Each of the Reporting Persons affirms that no person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock owned by the Reporting Persons.

(e)       Based on the number of shares of Common Stock outstanding as of July 31, 2020, as reported in the 8-K, on July 31, 2020, Mr. Marx ceased to be the owner of more than five percent of the Common Stock.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Other than as indicated elsewhere in this Statement, none of the persons named in Item 2(a) above is a party to any contract, arrangement, understanding, or relationship described in Item 6 of Schedule 13D.

Item 7. Material to Be Filed as Exhibits:

None.

Signatures

After reasonable inquiry and to the best of each undersigned’s knowledge and belief, each undersigned certifies that the information set forth in this statement is true, complete and correct.